XBiotech (XBIT) Competitors $2.87 -0.10 (-3.37%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.86 0.00 (-0.17%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT vs. CKPT, SNDL, TRDA, OLMA, BNTC, ARCT, HRTX, SEPN, FULC, and ATYRShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Checkpoint Therapeutics (CKPT), SNDL (SNDL), Entrada Therapeutics (TRDA), Olema Pharmaceuticals (OLMA), Benitec Biopharma (BNTC), Arcturus Therapeutics (ARCT), Heron Therapeutics (HRTX), Septerna (SEPN), Fulcrum Therapeutics (FULC), and Atyr PHARMA (ATYR). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. Checkpoint Therapeutics SNDL Entrada Therapeutics Olema Pharmaceuticals Benitec Biopharma Arcturus Therapeutics Heron Therapeutics Septerna Fulcrum Therapeutics Atyr PHARMA Checkpoint Therapeutics (NASDAQ:CKPT) and XBiotech (NASDAQ:XBIT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability. Do insiders and institutionals hold more shares of CKPT or XBIT? 22.0% of Checkpoint Therapeutics shares are held by institutional investors. Comparatively, 55.7% of XBiotech shares are held by institutional investors. 2.1% of Checkpoint Therapeutics shares are held by insiders. Comparatively, 33.1% of XBiotech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, CKPT or XBIT? Checkpoint Therapeutics has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, XBiotech has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Is CKPT or XBIT more profitable? Checkpoint Therapeutics' return on equity of 0.00% beat XBiotech's return on equity.Company Net Margins Return on Equity Return on Assets Checkpoint TherapeuticsN/A N/A -659.07% XBiotech N/A -15.99%-14.85% Which has higher valuation and earnings, CKPT or XBIT? XBiotech has higher revenue and earnings than Checkpoint Therapeutics. Checkpoint Therapeutics is trading at a lower price-to-earnings ratio than XBiotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheckpoint Therapeutics$41K8,539.84-$51.85M-$1.29-3.24XBiotech$4.01M21.82-$24.56M-$1.29-2.22 Do analysts recommend CKPT or XBIT? Checkpoint Therapeutics currently has a consensus target price of $4.33, indicating a potential upside of 3.67%. Given Checkpoint Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Checkpoint Therapeutics is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Checkpoint Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor CKPT or XBIT? XBiotech received 135 more outperform votes than Checkpoint Therapeutics when rated by MarketBeat users. Likewise, 69.98% of users gave XBiotech an outperform vote while only 67.16% of users gave Checkpoint Therapeutics an outperform vote. CompanyUnderperformOutperformCheckpoint TherapeuticsOutperform Votes18267.16% Underperform Votes8932.84% XBiotechOutperform Votes31769.98% Underperform Votes13630.02% Does the media prefer CKPT or XBIT? In the previous week, Checkpoint Therapeutics and Checkpoint Therapeutics both had 1 articles in the media. Checkpoint Therapeutics' average media sentiment score of 0.56 beat XBiotech's score of 0.54 indicating that Checkpoint Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Checkpoint Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive XBiotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCheckpoint Therapeutics beats XBiotech on 8 of the 15 factors compared between the two stocks. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.50M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-2.668.9226.7719.71Price / Sales21.82253.80393.17117.39Price / CashN/A65.8538.2534.62Price / Book0.406.466.794.50Net Income-$24.56M$143.98M$3.23B$248.18M7 Day Performance-3.69%2.03%1.53%0.20%1 Month Performance-8.01%4.11%10.06%12.37%1 Year Performance-66.59%-2.87%16.74%7.04% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech0.6102 of 5 stars$2.87-3.4%N/A-67.2%$87.50M$4.01M-2.66100Positive NewsGap UpCKPTCheckpoint Therapeutics2.0391 of 5 stars$4.16-0.2%$4.33+4.2%+110.1%$348.46M$41,000.00-2.2610News CoveragePositive NewsSNDLSNDL3.0665 of 5 stars$1.32+2.3%$3.63+174.6%-44.5%$346.86M$927.61M-4.26580Positive NewsTRDAEntrada Therapeutics2.947 of 5 stars$8.82+5.3%$25.67+191.0%-51.0%$334.75M$172.22M5.55110News CoverageAnalyst ForecastAnalyst RevisionOLMAOlema Pharmaceuticals2.2647 of 5 stars$4.76+3.5%$27.67+481.2%-46.5%$325.40MN/A-2.1770BNTCBenitec Biopharma2.4171 of 5 stars$13.14-3.6%$24.71+88.1%+42.3%$319.64M$80,000.00-8.7020News CoverageAnalyst ForecastAnalyst RevisionARCTArcturus Therapeutics2.9267 of 5 stars$11.59+5.6%$59.20+410.8%-59.3%$314.33M$138.39M-5.22180HRTXHeron Therapeutics3.8615 of 5 stars$2.05-2.8%$5.50+168.3%-45.3%$312.76M$148.52M-11.39300Positive NewsSEPNSepterna2.0583 of 5 stars$6.98+4.3%$33.00+372.8%N/A$310.72M$1.08M0.00N/AEarnings ReportAnalyst RevisionFULCFulcrum Therapeutics0.7844 of 5 stars$5.68+5.8%$8.63+51.8%-18.2%$306.60M$80M-18.32100ATYRAtyr PHARMA2.8106 of 5 stars$3.24-1.2%$18.60+474.1%N/A$288.37M$235,000.00-3.4553Analyst Forecast Related Companies and Tools Related Companies CKPT Competitors SNDL Competitors TRDA Competitors OLMA Competitors BNTC Competitors ARCT Competitors HRTX Competitors SEPN Competitors FULC Competitors ATYR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIT Stock Free XBIT Stock Alerts